@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns2: <http://purl.org/spar/pro/> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/061102031503> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 061102031503" ;
    ns1:publicationDate "2004-06-02"^^xsd:date ;
    dcterms:title "The Psychotomimetic Effects Of Intravenous Delta-9-Tetrahydrocannabinol In Healthy Individuals: Implications For Psychosis" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/06105531143>,
        <https://w3id.org/oc/meta/id/061102048795>,
        <https://w3id.org/oc/meta/id/062504018565> ;
    ns2:isDocumentContextFor <https://w3id.org/oc/meta/ar/061109017235>,
        <https://w3id.org/oc/meta/ar/061109017236>,
        <https://w3id.org/oc/meta/ar/061109017237>,
        <https://w3id.org/oc/meta/ar/061109017238>,
        <https://w3id.org/oc/meta/ar/061109017239>,
        <https://w3id.org/oc/meta/ar/061109017240>,
        <https://w3id.org/oc/meta/ar/061109017241>,
        <https://w3id.org/oc/meta/ar/061109017242>,
        <https://w3id.org/oc/meta/ar/061109017243>,
        <https://w3id.org/oc/meta/ar/061109017244> ;
    ns4:embodiment <https://w3id.org/oc/meta/re/061101677726> ;
    ns4:partOf <https://w3id.org/oc/meta/br/061102032119> .